Medicine and Dentistry
Free Tissue Graft
100%
Head and Neck Cancer
59%
Wart Virus
56%
Systematic Review
56%
Oropharynx Squamous Cell Carcinoma
48%
Overall Survival
43%
Neck
43%
Oropharynx Carcinoma
38%
Head and Neck Squamous Cell Carcinoma
35%
Malignant Neoplasm
31%
Surgery
31%
Radiation Therapy
31%
Diseases
28%
Recurrent Disease
28%
Hazard Ratio
27%
Oral Cavity
27%
Neoplasm
25%
Squamous Cell Carcinoma
25%
Meta-Analysis
24%
Cancer
20%
Oral Cancer
20%
Neck Dissection
18%
Adjuvant Therapy
18%
Fibula
18%
Skull Base
17%
Head Reconstruction
17%
Neck Reconstruction
17%
Microvascular Reconstruction
16%
Odds Ratio
13%
Chemoradiotherapy
13%
Postoperative Complication
12%
Cisplatin
11%
Surgical Margin
11%
Lymph Node
11%
Base
10%
Surgical Infection
10%
Fistula
10%
Robot-Assisted Surgery
10%
Induction Chemotherapy
10%
Graft Failure
9%
Comorbidity
9%
Retrospective Cohort Study
9%
Quality of Life
9%
Tongue
9%
Parotidectomy
9%
Donor Site
8%
Bone Necrosis
8%
Gastrostomy
8%
T Cell
8%
Smoking
8%
Keyphrases
Head-and-neck Cancer
72%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
63%
High-risk Human Papillomavirus (HR-HPV)
43%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
42%
Head-and-neck
41%
Free Flap Reconstruction
40%
Overall Survival
32%
Free Flap
30%
Confidence Interval
27%
Flap
25%
Transoral Surgery
24%
Meta-analysis
24%
Neck Dissection
20%
Radiation Therapy
20%
Locally Advanced
19%
Adjuvant Therapy
19%
Risk Factors
18%
Hazard Ratio
18%
Tumor
17%
Systematic Meta-analysis
17%
Oral Cavity Cancer
16%
Fibula Free Flap
16%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
15%
Microvascular Reconstruction
15%
Cisplatin
15%
Nasopharyngeal Carcinoma
14%
Functional Outcome
14%
Head Neck Reconstruction
14%
Skull Base
14%
Resection
14%
Free Tissue Transfer
13%
Multi-institutional
13%
Surgery Therapy
12%
Phase II Trial
12%
National Cancer Database
12%
Positive Margins
12%
Prognostic Significance
11%
Flap Outcomes
11%
Flap Reconstruction
11%
Human Papillomavirus Negative
11%
Non-associated
11%
Extranodal Extension
10%
Multivariable
10%
Radial Forearm Free Flap
10%
Double Free Flap
10%
Induction Chemotherapy
10%
Locoregional Recurrence
10%
Odds Ratio
10%
Transoral Robotic Surgery
10%
Neoadjuvant
10%